Serum Vitamin D Levels and Long-Term Risk of Elderly-Onset Inflammatory Bowel Disease: A Large-Scale Prospective Cohort Study.
Study Design
- Tipo de Estudo
- Cohort Study
- Tamanho da Amostra
- 357656
- População
- UK Biobank participants without IBD (mean age 57.9)
- Duração
- 690 weeks
- Intervenção
- Serum Vitamin D Levels and Long-Term Risk of Elderly-Onset Inflammatory Bowel Disease: A Large-Scale Prospective Cohort Study. None
- Comparador
- Vitamin D sufficiency (>=75 nmol/L)
- Desfecho Primário
- Incident elderly-onset IBD
- Direção do Efeito
- Neutral
- Risco de Viés
- Low
Abstract
BACKGROUND: Vitamin D is considered as a potential immunomodulator in inflammatory bowel disease development; however, emerging evidence remains inconsistent. We aimed to investigate the prospective association between serum vitamin D level and long-term risk of elderly-onset inflammatory bowel disease in a large-scale cohort. METHODS: Participants without inflammatory bowel disease at enrollment from the UK Biobank were included. Baseline blood samples were collected and serum 25-hydroxyvitamin D (25[OH]D) levels were measured. Participants were classified as having vitamin D deficiency (< 50 nmol/L), insufficiency (50-75 nmol/L) or sufficiency (≥ 75 nmol/L) based on predefined cutoffs. Primary outcome was incident elderly-onset inflammatory bowel disease, including ulcerative colitis and Crohn disease. Hazard ratio (HR) and 95% confidence intervals (CIs) of related associations were determined using multivariable Cox regression. RESULTS: Among 357,656 participants (mean age, 57.9±6.9 years), 196,499 (54.9%) and 121,035 (33.8%) had vitamin D deficiency and insufficiency, respectively. During a median 13.3 years follow-up, 1622 elderly-onset inflammatory bowel disease cases were identified. Compared with vitamin D sufficiency, no associations with vitamin D deficiency (HR = 0.91; 95% CI, 0.78-1.07) or insufficiency (HR = 0.86; 95% CI, 0.73-1.01) were observed for elderly-onset inflammatory bowel disease. Similarly, no associations with per 10 nmol/L increase of serum 25(OH)D were detected for elderly-onset inflammatory bowel disease (HR = 1.00; 95% CI, 0.98-1.03), ulcerative colitis (HR = 1.00; 95% CI, 0.97-1.03), or Crohn disease (HR = 1.01; 95% CI, 0.97-1.05). Compared with the lowest quartile, no associations with higher quartiles of serum 25(OH)D were observed for inflammatory bowel disease (HRQ4VSQ1 = 1.03; 95% CI, 0.89-1.19), ulcerative colitis (HRQ4VSQ1 = 1.06; 95% CI, 0.90-1.26), or Crohn disease (HRQ4VSQ1 = 0.93; 95% CI, 0.73-1.20). Further sensitivity and subgroup analyses demonstrated similar results. CONCLUSIONS: Serum vitamin D level or deficiency status is not associated with the development of elderly-onset inflammatory bowel disease, ulcerative colitis, or Crohn disease.
Resumo Rápido
Serum vitamin D level or deficiency status is not associated with the development of elderly-onset inflammatory bowel disease, ulcerative colitis or Crohn's disease, and sensitivity and subgroup analyses demonstrated similar results.
Used In Evidence Reviews
Similar Papers
Journal of inflammation research · 2014
Vitamin D and inflammatory diseases.
Gastroenterology · 2017
Diet as a Trigger or Therapy for Inflammatory Bowel Diseases.
The journal of headache and pain · 2020
Gut-brain Axis and migraine headache: a comprehensive review.
Joint bone spine · 2010
Vitamin D and inflammation.
The Australian and New Zealand journal of psychiatry · 2017
A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.
World journal of gastroenterology · 2016